ABSTRACT Background Allogeneic stem cell transplantation is the only curative option for patients with hereditary bone marrow failure syndromes Umbilical cord blood is an alternative stem cell source for allotransplantation. Design and Methods This multicenter, retrospective study is based on data reported to Eurocord Registry about patients with hereditary bone marrow failure syndrome who received umbilical cord blood transplantation

http://www.lifelinecordblood.com/upload/20110104/1294146302-22614.pdf